EP2900280A1 - Blutstillendes pflaster und verfahren zur herstellung - Google Patents

Blutstillendes pflaster und verfahren zur herstellung

Info

Publication number
EP2900280A1
EP2900280A1 EP13766967.7A EP13766967A EP2900280A1 EP 2900280 A1 EP2900280 A1 EP 2900280A1 EP 13766967 A EP13766967 A EP 13766967A EP 2900280 A1 EP2900280 A1 EP 2900280A1
Authority
EP
European Patent Office
Prior art keywords
film
porous layer
chitosan
face
neutralizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP13766967.7A
Other languages
English (en)
French (fr)
Other versions
EP2900280B1 (de
Inventor
Aurélie SERRERO
Suzelei Montanari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sofradim Production SAS
Original Assignee
Sofradim Production SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofradim Production SAS filed Critical Sofradim Production SAS
Publication of EP2900280A1 publication Critical patent/EP2900280A1/de
Application granted granted Critical
Publication of EP2900280B1 publication Critical patent/EP2900280B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/0038—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding involving application of liquid to the layers prior to lamination, e.g. wet laminating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/12—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by using adhesives
    • B32B37/1284—Application of adhesive
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/24—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with at least one layer not being coherent before laminating, e.g. made up from granular material sprinkled onto a substrate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B38/00—Ancillary operations in connection with laminating processes
    • B32B38/16—Drying; Softening; Cleaning
    • B32B38/162—Cleaning
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2305/00—Condition, form or state of the layers or laminate
    • B32B2305/02—Cellular or porous
    • B32B2305/026—Porous
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2317/00—Animal or vegetable based
    • B32B2317/18—Cellulose, modified cellulose or cellulose derivatives, e.g. viscose
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2535/00—Medical equipment, e.g. bandage, prostheses or catheter
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2555/00—Personal care
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor

Definitions

  • the present invention relates to a method of preparing a haemostatic patch comprising a porous layer, for example a textile, based on oxidized cellulose and a film based on neutralized chitosan fixed on one of the faces of the porous layer.
  • Haemostatic patches are implantable medical devices for stopping the flow of biological fluids such as blood during surgery.
  • they are generally composed of an absorbent porous layer, which is intended to trap the biological fluids, and a barrier known as a haemostatic barrier, which is intended to block the passage of the biological fluids.
  • haemostatic patches can be completely bioabsorbable, i.e. they are made to disappear in vivo after implantation, after a few weeks for example, when their function of stopping the effusion of biological fluids is no longer necessary.
  • Oxidized cellulose is of interest as a bioabsorbable material that can constitute the absorbent porous layer of a haemostatic patch: in fact, oxidized cellulose possesses intrinsic haemostatic properties.
  • Chitosan is a polysaccharide obtained by deacetylation of chitin.
  • Chitin is one of the most widespread naturally occurring polysaccharides and is extracted from the exoskeletons of arthropods, from the endoskeletons of cephalopods as well as from fungi.
  • Chitosan has properties, such as biodegradability, bioabsorbability, biocompatibility, non-toxicity, and mechanical properties, th at make it particularly interesting for medical applications.
  • properties such as biodegradability, bioabsorbability, biocompatibility, non-toxicity, and mechanical properties, th at make it particularly interesting for medical applications.
  • Chitosan in fact offers a good compromise, taking into account the properties that are required, for a haemostatic barrier, namely good biocompatibility and good mechanical properties.
  • chitosan is generally soluble in a n acid environment.
  • the films obtained from acid solutions based on chitosan are still highly laden with salts and still have their acid character.
  • a chitosan film obtained from an acidic solution of chitosan can thus degrade and disintegrate when it is brought in contact with water or biological fluids. Therefore it can no longer perform its function of haemostatic barrier.
  • chitosan films must be neutralized. Generally this neutralization is obtained by treating these films with a strong base such as sodium hydroxide.
  • the present invention relates to a method of preparing a haemostatic patch comprising a porous layer based on oxidized cellulose and a neutralized film based on chitosan, said film comprising a free face and a face fixed on one of the faces of the porous layer, comprising the following steps:
  • step c° can be carried out before or after step d°), characterized in that:
  • the neutralizing step d°) comprises treatment of said film with a neutralizing composition comprising at least ethanol and ammonium hydroxide (NH 4 OH).
  • a film based on chitosan is manufactured starting from an acidic solution, then this film, alone or already fixed on the porous layer based on oxidized cellulose, is treated in order to neutralize it and obtain a final product usable in contact with biological fluids, without destroying the porous layer to which this film is attached.
  • the neutralizing composition of the method of the invention comprising at least ethanol and ammonium hydroxide (NH OH)
  • NH OH ammonium hydroxide
  • a haemostatic patch having a film of neutralized chitosan as barrier, with a porous layer fixed to this film, said porous layer being based on oxidized cellulose, or said porous layer consisting of oxidized cellulose.
  • the present invention further relates to a haemostatic patch comprising a porous layer based on oxidized cellulose and a film based on chitosan fixed to one face of said porous layer, characterized in that said film is in neutralized form.
  • the present invention further relates to a haemostatic patch obtained by the method herein described, comprising a porous layer based on oxidized cellulose and a film based on chitosan fixed to one face of said porous layer, characterized in that said film is in neutralized form.
  • the treatment in step d°) comprises a succession of operations of contacting at least the face that is free, or is intended to be free, of the film with said neutralizing composition.
  • the treatment in step d°) will essentially consist of contacting only the free face of the film with the neutralizing composition, preferably without contacting the porous layer, on which the film will already be fixed: in fact, contact of the porous layer with the neutralizing composition could affect the integrity of the latter.
  • the treatment in step d°) can comprise immersing the whole film, i.e.
  • step d°) further comprises a step of washing of said face of said film that is free, or intended to be free, after said treatment with the neutralizing composition.
  • the washing step comprises one or more operations of rinsing of at least said face of said film that is free, or intended to be free, with an ethanol/water composition followed by washing with water.
  • the film is fixed to the porous layer before it is neutralized, only its free face will be washed after application of the neutralizing composition.
  • the whole film can be immersed in an ethanol/water composition and/or in water.
  • the fixing step c°) is carried out before the neutralizing step d°).
  • the acidic aqueous solution of chitosan is poured into a mould in the form of one or more layers, which are left to dry by evaporation of the water from said solution in order to obtain a film, then, according to step c°), before the end of the drying step of step b°), one face of the porous layer of oxidized cellulose is deposited on said film, complete drying of the film thus resulting in fixation of the porous layer on the film.
  • the treatment in step d°) comprises application of said neutralizing composition on the free face of the film, said neutralizing composition further comprising water.
  • said neutralizing composition can for example consist of an ethanol/water/ammonium hydroxide mixture i n th e proportions 80/16/14 by weight.
  • the neutralizing composition is applied on the free face of the film one or more times using a brush.
  • the bristles of a brush are soaked in neutralizing composition consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight and the free face of the film is brushed: several passes of the brush can be carried out, for example 3 passes.
  • the film is thus neutralized.
  • the film is then washed, as described above: for example, another brush is u sed , wh ich is soa ked with an ethanol/water composition, for example in the proportions 50/50 by weight.
  • Several passes of the brush can be carried out, for example three. A last pass with a brush soaked in just water can be carried out to finalize the washing.
  • the neutralizing step d°) is carried out before the fixing step c°).
  • the acidic aqueous solution of chitosan is poured into a mould in the form of one or more layers, which are left to dry by evaporation of the water until a film is obtained, which is removed from the mould, then, according to step d°), the treatment of the film obtained in b°) comprises immersing said film in said neutralizing composition, preferably for 30 m in utes.
  • the film is completely dry and can be handled, it is immersed completely in a bath of neutralizing composition.
  • both faces of the film are treated with the neutralizing composition.
  • the neutralizing composition can consist of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight.
  • the chitosan-based film is thus neutralized.
  • the film can then be washed, as described above: for example, the film is immersed one or more times in baths of an ethanol/water composition, for example in the proportions 50/50 by weight, until a pH close to 7 is obtained for the washing baths.
  • the film can then be submitted to a last bath of water only, to finalize the washing.
  • the neutralized film obtained at the end of step d°) can be fixed on one face of the porous layer of oxidized cellulose by means of a glue obtained starting from an acidic solution of chitosan.
  • said glue is spread on one face of the porous layer and/or on the face of the film intended to be fixed to the porous layer, and the film is fixed to the porous layer by application of the film on said face of the porous layer with pressure. The integrity of the porous layer based on oxidized cellulose is not affected during this fixing step.
  • a plasticizer for example glycerol
  • glycerol can be added to the acidic aqueous solution of chitosan intended to form said chitosan-based film.
  • a chitosan film can finally be obtained that has excellent mechanical properties.
  • the porous layer is a textile, preferably a three-dimensional knitted fabric.
  • Said porous layer in the form of three-dimensional knitted fabric, gives excellent absorption of biological fluids, especially of blood.
  • FIG. 1A-1 C are sectional views showing the various steps of a first implementation of the method according to the invention.
  • FIG. 2A-2E are sectional views showing the various steps of a second implementation of the method according to the invention.
  • a porous layer based on oxidized cellulose is provided.
  • “Based on oxidized cellulose” means, according to the present application, that the main component of the porous layer is oxidized cellulose.
  • the porous layer can further comprise other biocompatible, preferably bioabsorbable, materials.
  • the porous layer can comprise, as other bioabsorbable materials, synthetic polymers such as polylactic acid and/or polymers of natural origin such as chitosan.
  • Oxidized cellulose is a known bioabsorbable material. It can for example be selected from oxidized cellulose, where the Ce primary alcohol is partially or fully oxidized to carboxylic acid, for example to give polyglucuronic acid, oxidized cellulose in the form of polyaldehydes by periodic acid, and mixtures thereof.
  • the cellulose used for oxidation can be obtained from type I cellulose or can be regenerated.
  • regenerated cellulose has been developed industrially.
  • viscose which is based on the solubility of cellulose xanthate in a dilute solution of sodium hydroxide.
  • cupro-ammonium process employed for example by the company Bemberg in Italy or the company Asahi Chemical Industries in Japan, which consists of dissolving cellulose in an ammoniacal solution of copper.
  • Another method of preparing regenerated cellulose suitable for the present invention is the method of organic-phase dissolution of cellulose by N-methylmorpholine oxide (N.M.M.O.), called the “Lyocell® process", employed for example by the company Lenzing in Austria.
  • porous layer means a layer having pores, or voids, cells, holes, orifices, distributed regularly or irregularly, not only on the surface but also within the thickness of said layer, and more or less interconnected. Said porous layer is particularly effective for absorbing biological fluids such as blood.
  • the porous layer based on oxidized cellulose is in the form of a textile openwork based on oxidized cellulose.
  • textile means any arrangement or assemblage of biocompatible threads, fibres, filaments and/or multifilaments, for exam ple obta ined by kn itting, weaving, braiding, or alternatively non-woven.
  • the arrangement of threads of the textile according to the invention defines at least two opposite faces, a first face and a second face.
  • textile openwork means any textile whose arrangement of threads of which it is constituted determines openings, cells or voids in the thickness of the textile and on the faces of the textile, and these openings, cells or voids can constitute channels with openings on either side of the textile. This textile openwork gives good absorption of biological fluids.
  • the textile can be in the form of a two-dimensional or three- dimensional knitted fabric.
  • “Two-dimensional knitted fabric” means, in the sense of the present application, a knitted fabric having two opposite faces joined together by stitches but lacking cross-members giving it a certain thickness: a knitted fabric of this kind can be obtained for example by knitting threads on a warp knitting machine or Raschel machine using two guide bars. Examples of knitting of two- dimensional knitted fabrics suitable for the present invention are g iven in document WO2009/071998.
  • Three-dimensional knitted fabric means, according to the present application, a knitted fabric having two opposite faces joined together by a cross-member giving the knitted fabric a significant thickness, said cross- member itself being formed of additional connecting threads supplementary to the threads forming the two faces of the knitted fabric.
  • This knitted fabric can be obtained for example on a warp knitting machine or double-bed Raschel machine using several guide bars. Examples of knitting of three-dimensional knitted fabrics suitable for the present invention are g iven in documents WO99/05990, WO2009/031035, WO2009/071998.
  • This kind of three-dimensional knitted fabric with the presence of a cross-member giving it a significant thickness, provides excellent absorption of biological fluids such as blood and is particularly suitable for manufacture of the haemostatic patch of the invention.
  • a knitted fabric in particular three-dimensional, based on oxidized cellulose, can be obtained by knitting firstly threads of unoxidized regenerated cellulose, then submitting the knitted fabric thus obtained to oxidation.
  • this regenerated cellulose thread is not absorbable. However, it has good mechan ical strength a l l owi ng it to be u sed for manufacturing a kn itted fabric.
  • regenerated cellulose thread suitable for manufacturing a knitted fabric suitable for the porous layer of the patch of the invention the 90 decitex multifilament thread marketed under the name "CUPRO® Cusio" by the Ital ian company Bemberg.
  • the knitted fabric obtained is then oxidized in order to form a porous layer based on oxidized cellulose suitable for the haemostatic patch and for the method of preparing said patch according to the present invention.
  • the porous layer based on oxidized cellulose is a three-dimensional knitted fabric made from oxidized cellulose.
  • step b) a film based on chitosan is prepared starting from an acidic aqueous solution of chitosan.
  • chitosan-based film can further comprise other compounds.
  • the chitosan-based film can comprise a plasticizer, for example glycerol, to improve the mechan ical properties of the film.
  • Chitosan is a biocompatible biopolymer obtained by deacetylation of chitin. Chitin is extracted from exoskeletons of arthropods such as the lobster, crab, prawn, the endoskeleton of cephalopods such as the squid, or from fungi. Extraction of chitin involves steps of hydrolysis of the proteins and lipids, depigmentation and demineralization. Hydrolysis of the proteins and lipids is usually carried out in the presence of sodium hydroxide, and demineralization requires the use of hydrochloric acid.
  • chitosan is obtained by a deacetylation step, which consists of hydrolysis of the acetamide groups. This reaction is generally carried out at high temperature in an alkaline solution, for example a 48% solution of sodium hydroxide (NaOH) in water, at 90°C.
  • Chitosan is a compound that is soluble in aqueous solution and can have a degree of acetylation (DA) of up to 70%.
  • Chitosan is a bioabsorbable compound.
  • the degree of acetylation of chitosan can have an influence on the kinetics of degradation of chitosan.
  • the chitosan will have to have a degree of acetylation of 2, 10, 20, 30, 40, 50, 60 or 70%.
  • the degree of acetylation of the chitosan ranges from 2 to 70%. With this chitosan it is possible to obtain a film having optimum degradation kinetics for the manufacture of haemostatic patches.
  • the chitosan solution in step b) of the method according to the invention is generally prepared starting from a solution of chitosan in water, with the concentration of chitosan in said solution ranging for example from 0.25% to 10%, by weight, relative to the total weight of the solution, to which an acid is added in stoichiometric proportion, said acid being selected for example from acetic acid, hydrochloric acid and mixtures thereof.
  • the concentration of chitosan in the starting aqueous solution can range from 0.25% to 5%, by weight, relative to the total weight of the solution.
  • the pH of the acidic aqueous solution of chitosan is from 2.5 to 5.5.
  • the acidic aqueous solution of chitosan is poured into a mould in order to form a layer.
  • the acidic aqueous solution can be cast in the mould in the form of one or more layers, depending on the final thickness that is desired for the barrier film of the haemostatic patch.
  • the mould is of rectangular shape having dimensions compatibl e with th e u se of the film obtained as part of a haemostatic patch.
  • the layer or layers of acidic aqueous solution are left to dry for evaporation of the water present in th e acidic aqueous starting solution. Generally this drying step is carried out under a laminar-flow hood.
  • step b°) of formation of the chitosan-based film the water of the acidic aqueous starting solution is evaporated but the acid remains in the film.
  • the film obtained is therefore of an acidic character. This film cannot be used as it is for forming the barrier of the haemostatic patch of the invention, as it would disintegrate very rapidly merely in contact with biological fluids.
  • the method according to the invention comprises a step of neutralizing the film obtained in b°), and this neutralizing step can be carried out before or after the fixing step.
  • a first embodiment of the method according to the invention will be described first, according to which, firstly, the film is fixed to the porous layer based on oxidized cellulose, then it is neutralized, while it is already fixed on the porous layer based on oxid ized cellulose.
  • a second embodiment of the method according to the invention will then be described, according to which the film is neutralized first, then it is fixed to the porous layer based on oxidized cellulose.
  • the porous layer of oxidized cellulose in particular the three-dimensional knitted fabric, is deposited on the last layer of acidic aqueous solution based on chitosan that is cast.
  • the porous layer for example the three-dimensional knitted fabric, penetrates superficially within the last layer cast that is drying.
  • the film traps the portion of the porous layer, for example of the three-dimensional knitted fabric, that had slightly penetrated into said last layer cast, and the porous layer is thus fixed to the film.
  • the neutralizing treatment is carried out on the face of the film that has been left free, i.e. on the face of the film that is not attached to the porous layer, in particular to the textile or knitted fabric based on oxidized cellulose.
  • the neutralizing composition is applied on the free face of the film one or more times with a brush, taking care that the neutralizing composition does not come in contact with the porous layer based on oxidized cellulose.
  • the bristles of a brush are soaked with neutralizing composition consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight and the free face of the film is brushed or painted: several passes of the brush can be carried out, for example 3 passes.
  • This formulation for the neutralizing composition makes it possible to avoid shrinkage of the film during this neutralizing step.
  • said formulation for the neutralizing composition and said number of passes make it possible to carry out effective neutralization of the chitosan-based film, both at the surface and throughout its thickness, without damaging the integrity of the porous layer on which the film is already fixed.
  • the film thus loses its acid character and is neutralized.
  • the film can then be washed: for example, another brush is used, which is soaked with an ethanol/water composition, for example in the proportions 50/50 by weight, and which is brushed over the free face of the film, still without contacting the porous layer, for example the three-dimensional knitted fabric, based on oxidized cellulose.
  • Several passes of the brush can be carried out, for example three, or up to five.
  • a last pass with a brush soaked in water only can be carried out to finalize the washing.
  • the cast layers of acidic aqueous solution from step b°) of formation of the thread are left to dry by complete evaporation of the water and until a film is obtained that can easily be removed from the mould and handled.
  • the chitosan-based film thus obtained wh ich has not been neutralized, can be submitted to one or more operations of immersion in baths of said neutralizing composition.
  • the film can be immersed in a bath of neutralizing composition preferably for 30 minutes.
  • both faces of the chitosan-based film are treated with the neutralizing composition.
  • the neutralizing composition can consist of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight.
  • This formulation for the neutralizing composition of the method of the invention makes it possible to carry out effective neutralization of the film, both on the surface of the film and in its thickness, without damaging the integrity of the porous layer during the next step of fixation of the film on the porous layer based on oxidized cellulose.
  • the chitosan-based film After im mersion in a bath of the neutralizing composition as described above, the chitosan-based film has lost its acid character and it is neutralized.
  • the film can then be washed: for example, the film is immersed one or more times in baths of an ethanol/water composition, for example in the proportions 50/50 by weight, until a pH close to 7 is obtained for the washing baths.
  • the film can then be submitted to a last bath of water only to finalize the washing.
  • the neutralized film obtained at the end of step d°) can be fixed on one face of the porous layer of oxidized cellulose, for example on the three-dimensional knitted fabric, by means of a glue obtained starting from an acidic solution of chitosan.
  • a glue obtained starting from an acidic solution of chitosan.
  • said glue is spread on one face of the porous layer and/or on the face of the film intended to be fixed to the porous layer, and the film is fixed to the porous layer by application of the film on said face of the porous layer with pressure.
  • the integrity of the porous layer based on oxidized cellulose is not affected during this fixing step.
  • a patch comprising a porous layer based on oxidized cellulose, for example a three-dimensional knitted fabric, and a film based on chitosan fixed to one face of this porous layer, the film being in neutralized form.
  • This patch can be used effectively as a haemostatic patch for stopping effusion of blood during a surgical operation.
  • this patch can be completely bioabsorbable: it can thus disappear in the weeks following its implantation, for example in less than 4 weeks, once its haemostatic function is no longer required. This thus avoids introducing a foreign body into a patient's body permanently.
  • a textile of oxidized cellulose 1 wh ich is a porous three- dimensional knitted fabric, as shown in Fig. 1 A, is provided.
  • This textile is bioabsorbable.
  • An acidic solution based on chitosan is prepared by adding acetic acid in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and with a molecular weight of 550 000 Da at 10 wt% in water. 25 wt% of glycerol is added. The presence of glycerol in the acidic starting solution of chitosan then makes it possible to obtain a film that has good mechanical properties.
  • the acidic solution thus obtained 2 is poured into a rectangular mould 3 as shown in Fig. 1 A: for example, from 8 to 30 ml of acidic solution is poured into a mould with dimensions of 10x15 cm. After evaporation of the water present in the solution, a film is obtained.
  • the solution can be cast in the mould in the form of several successive layers so that a thicker film is finally obtained.
  • three successive layers of acidic solution can be cast.
  • one face of the textile of oxidized cellulose 1 cut to the dimensions of the mould, is deposited on this layer as shown in Fig. 1 .
  • the textile becomes fixed to the film obtained once the water has evaporated.
  • a textile of oxidized cellulose 1 with a film 4 of chitosan fixed on one of its faces is thus obtained, as shown in Fig . 1 B.
  • the chitosan film still has an acidic character and has not been neutralized.
  • a neutralizing composition is prepared, consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight.
  • a brush 5 is soaked with this neutralizing composition and is applied on the free face of the chitosan film 4, i.e. on the face of the chitosan film which is not attached to the textile of oxidized cellulose 1 , as shown in Fig. 1 C.
  • the neutralizing composition is applied on said face of the film at least three times.
  • This formulation for the neutralizing composition makes it possible to avoid shrinkage of the film during this neutralizing step.
  • the neutralization is effective: the film can then be washed with aqueous solutions without risk of redissolving.
  • the neutralized film is rinsed by application of a brush soaked in an ethanol/water mixture in proportions of 50/50 by weight. This mixture can be applied several times, preferably up to three times.
  • the film is then washed with water (100% water), either by application of a brush soaked with water, or by immersing in a water bath.
  • the textile thus obtained with one of its faces covered with a film of neutralized chitosan, can be used as haemostatic patch 6 and can be implanted in a human body without risk of the chitosan film disintegrating and disappearing in contact with biological fluids.
  • the textile part, wh ich is a three-dimensional knitted fabric of oxidized cellulose 1 , thus forms a porous layer capable of absorbing blood.
  • the film of neutralized chitosan, for its part does not degrade in contact with biological fluids, and it acts as a haemostatic barrier.
  • the whole patch 6, namely the textile part and the film, is bioabsorbable and disappears in less than 4 weeks after implantation.
  • Said patch 6 is particularly useful for stopping effusions of blood during surgery.
  • Said patch is completely bioabsorbable and disappears in less than 4 weeks after implantation, when its haemostatic function is no longer required.
  • An acidic solution based on chitosan is prepared by adding acetic acid in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and a molecular weight of 550 000 Da at 10 wt% in water. 25 wt% of glycerol is added. The presence of glycerol in the acidic starting solution of chitosan then makes it possible to obtain a film that has good mechanical properties.
  • the acidic solution 2 thus obtained is poured into a rectangular mould 3 as shown in Fig. 2A: for example, from 8 to 30 ml of acidic solution is poured into a mould with dimensions of 10x15 cm. After evaporation of the water present in the solution, a film 4 is obtained, as shown in Fig. 2B.
  • the solution can be cast in the mould in the form of several successive layers so that a thicker film is finally obtained. For example, three successive layers of acidic solution are cast.
  • the layers are left to dry for 2h at room temperature.
  • the chitosan film 4 obtained is of an acid character and has not been neutralized. In order to neutralize it, it is immersed in a neutralizing composition 5 consisting of a n ethanol/ammonium hydroxide mixture in the proportions 80/20 by weig ht: for example, film 4 is immersed in said composition for 30 minutes in an orbital stirrer 6, as shown in Fig. 2C.
  • a neutralizing composition 5 consisting of a n ethanol/ammonium hydroxide mixture in the proportions 80/20 by weig ht: for example, film 4 is immersed in said composition for 30 minutes in an orbital stirrer 6, as shown in Fig. 2C.
  • the neutralization is effective: the film can then be washed in aqueous solutions without risk of redissolving.
  • the neutralized film is rinsed by successive operations of immersion, for example three times, in baths of an ethanol/water mixture in proportions of 50/50 by weight until a pH of 7 is obtained for the rinsing mixture.
  • the film is then washed by immersing in a water bath (100% water).
  • the film is then left to dry in spread-out form to avoid the formation of creases in the film.
  • the film of neutralized chitosan thus obtained 7 is then fixed on one face of a textile of oxidized cellulose by means of a glue based on chitosan as explained below, referring to Figs. 2D and 2E.
  • acetic acid is added in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and a molecular weight of 550 000 Da at 10 wt% in water.
  • the glue obtained 8 is spread on one face of the film of neutralized chitosan 7 as shown in Fig . 2D.
  • the glue could be spread on the face of the textile for fixing to the film, or both on one face of the film and on the face of the textile to be attached to the film.
  • a textile of oxidized cellulose 9 is provided, which is a porous three- dimensional knitted fabric as shown in Fig. 2E. This textile is bioabsorbable.
  • the textile of oxidized cellulose 9 is applied with pressure on the glue 8, as shown in Fig . 2E, and the film 7 of neutralized chitosan is thus fixed to the textile 9.
  • the "textile + film” assembly can then be dried under a laminar-flow hood.
  • a textile of oxidized cellulose is thus obtained with a chitosan film fixed on one of its faces, said film having been neutralized.
  • the textile of oxidized cellulose has not been damaged by the step of neutralization of the chitosan film and th is textile has preserved its integrity.
  • the chitosan-based film has a good, smooth and crease- free appearance.
  • the textile thus obtained with one of its faces covered with a film of neutralized chitosan, can be used as haemostatic patch 10 and ean be implanted in a human body without risk of the chitosan film 7 disintegrating and disappearing in contact with biological fluids.
  • the textile part which is a three-dimensional knitted fabric of oxidized cellulose, thus forms a porous layer capable of absorbing blood.
  • the film of neutralized chitosan, for its part, does not degrade in contact with biological fluids, and it acts as a haemostatic barrier.
  • the whole of patch 10, namely the textile part and the film, is bioabsorbable and disappears in less than 4 weeks after implantation.
  • Said patch 10 is particularly useful for stopping effusions of blood during surgery.
  • This patch is completely bioabsorbable and disappears in less than four weeks after implantation, when its haemostatic function is no longer required.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials For Medical Uses (AREA)
EP13766967.7A 2012-09-25 2013-09-25 Blutstillendes pflaster und verfahren zur herstellung Active EP2900280B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1258965A FR2995788B1 (fr) 2012-09-25 2012-09-25 Patch hemostatique et procede de preparation
PCT/EP2013/069957 WO2014048982A1 (en) 2012-09-25 2013-09-25 Haemostatic patch and method of preparation

Publications (2)

Publication Number Publication Date
EP2900280A1 true EP2900280A1 (de) 2015-08-05
EP2900280B1 EP2900280B1 (de) 2018-08-01

Family

ID=47257941

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13766967.7A Active EP2900280B1 (de) 2012-09-25 2013-09-25 Blutstillendes pflaster und verfahren zur herstellung

Country Status (6)

Country Link
US (1) US9750837B2 (de)
EP (1) EP2900280B1 (de)
AU (1) AU2013322689B2 (de)
CA (1) CA2879765C (de)
FR (1) FR2995788B1 (de)
WO (1) WO2014048982A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10517988B1 (en) 2018-11-19 2019-12-31 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10328178B2 (en) 2014-05-30 2019-06-25 Sofradim Production Implant comprising oxidized cellulose and method for preparing such an implant
EP4403194A3 (de) 2018-11-19 2024-10-16 Endomedix, Inc. Verfahren und zusammensetzungen zur erzielung von hämostase und stabiler blutgerinnselbildung

Family Cites Families (506)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124136A (en) 1964-03-10 Method of repairing body tissue
US3118294A (en) 1964-01-21 Method for manufacturing knitted nets and products
US1187158A (en) 1915-02-18 1916-06-13 Simon Friedberger Twisted net fabric.
US3054406A (en) 1958-10-17 1962-09-18 Phillips Petroleum Co Surgical mesh
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US3320649A (en) 1962-10-23 1967-05-23 Naimer Jack Methods of making separable fastening fabrics
US3276448A (en) 1962-12-14 1966-10-04 Ethicon Inc Collagen coated fabric prosthesis
US3272204A (en) 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
SE344275B (de) 1966-02-10 1972-04-10 R Gruenert
US3570482A (en) 1968-12-09 1971-03-16 Fujiboseki Kk Elastic surgical bandage
US3718725A (en) 1970-11-17 1973-02-27 Int Knitlock Corp Method for making hook fabric material for fasteners
IT993386B (it) 1973-09-24 1975-09-30 Nannini G E C Sas Procedimento per la realizzazione di un pizzo in un telaio tipo raschel e pizzo ottenuto
DE2461370A1 (de) 1974-01-02 1975-07-03 Sauvage Lester R Poroese vaskulaere prothese
US4006747A (en) 1975-04-23 1977-02-08 Ethicon, Inc. Surgical method
US4060081A (en) 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US4193137A (en) 1977-05-06 1980-03-18 Meadox Medicals, Inc. Warp-knitted double-velour prosthesis
US4294241A (en) 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4173131A (en) 1977-08-30 1979-11-06 The Kendall Co. Porous elastic bandage
US4307717A (en) 1977-11-07 1981-12-29 Lectec Corporation Sterile improved bandage containing a medicament
US4248064A (en) 1979-02-14 1981-02-03 Stedman Corporation Lock-stitch knitted elastic fabric
US4307496A (en) 1979-02-19 1981-12-29 Takeda Lace Co., Ltd. Warp-knitted lace strip, material fabric, and manufacturing method thereof
BR8000993A (pt) 1979-02-19 1980-10-29 Takeda Lace Tira e tecido de renda totalmente urididos e processo para a sua fabricacao
JPS6027281B2 (ja) 1979-05-09 1985-06-28 ワイケイケイ株式会社 ベルベツト式フアスナ−用テ−プの製造方法
US4476697A (en) 1980-04-21 1984-10-16 Karl Otto Braun Kg Wound dressing
DE3042860A1 (de) 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
US4591501A (en) 1981-04-13 1986-05-27 Seton Company Cosmetic and pharmaceutical sheet material containing polypeptides
FR2516927B1 (fr) 1981-11-26 1986-05-23 Merieux Fond Procede de preparation industrielle de materiaux collageniques a partir de tissus placentaires humains, materiaux collageniques humains obtenus, leur application comme biomateriaux
US4925294A (en) 1986-12-17 1990-05-15 Geshwind David M Method to convert two dimensional motion pictures for three-dimensional systems
JPS6014861A (ja) 1983-07-05 1985-01-25 株式会社日本メデイカル・サプライ 癒着防止材
US4487865A (en) 1983-12-15 1984-12-11 Biomatrix, Inc. Polymeric articles modified with hyaluronate
US4500676A (en) 1983-12-15 1985-02-19 Biomatrix, Inc. Hyaluronate modified polymeric articles
FR2559780B1 (fr) 1984-02-21 1990-05-04 Tech Cuir Centre Systemes biocompatibles implantables a base de collagene permettant la conservation et/ou la culture cellulaires et/ou la liberation controlee de principes actifs
MX163953B (es) 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
US4837285A (en) 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
FR2577807B1 (fr) 1985-02-22 1993-12-03 Ethnor Materiau chirurgical composite absorbable, procede de preparation, prothese resorbable realisee a partir d'un tel materiau et utilisation d'une telle prothese
US4631932A (en) 1985-05-15 1986-12-30 S.R.C. Textiles, Inc. Knitted waistband curl-preventing strip
US5720981A (en) 1985-08-14 1998-02-24 Sloan-Kettering Institute For Cancer Research Epidermal cell extracts and method to enhance wound healing and regenerate epidermis
US5002551A (en) 1985-08-22 1991-03-26 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
JPH0235207Y2 (de) 1985-10-23 1990-09-25
EP0228203B1 (de) 1985-12-05 1990-07-25 Sakae Lace Co. Ltd. Kettengewirkte Spitzen
US4792336A (en) 1986-03-03 1988-12-20 American Cyanamid Company Flat braided ligament or tendon implant device having texturized yarns
US4769038A (en) 1986-03-18 1988-09-06 C. R. Bard, Inc. Prostheses and techniques and repair of inguinal and femoral hernias
GB8611129D0 (en) 1986-05-07 1986-06-11 Annis D Prosthetic materials
DE3619197A1 (de) 1986-06-07 1987-12-10 Ethicon Gmbh Polsterartiges implantat
FR2601371B1 (fr) 1986-07-11 1989-05-12 Merieux Inst Procede de traitement du collagene en vue, notamment, d'en faciliter la reticulation et collagene obtenu par application dudit procede
US4854316A (en) 1986-10-03 1989-08-08 Davis Emsley A Apparatus and method for repairing and preventing para-stomal hernias
DE3633974A1 (de) 1986-10-06 1988-04-21 Bleier Waldemar Bleier-clips
US4759354A (en) 1986-11-26 1988-07-26 The Kendall Company Wound dressing
IT1202456B (it) 1987-01-30 1989-02-09 Ausonia Spa Manufatto tessile per chiusura a contatto e metodo ed apparecchiatura per la sua produzione
US4813942A (en) 1987-03-17 1989-03-21 Bioderm, Inc. Three step wound treatment method and dressing therefor
FR2612392A1 (fr) 1987-03-19 1988-09-23 Audion Michel Composites biodegradables interrompus a resistance variable
US4937270A (en) 1987-09-18 1990-06-26 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US5015584A (en) 1987-10-14 1991-05-14 Board Of Regents, The University Of Texas System Epidermal graft system
US4976737A (en) 1988-01-19 1990-12-11 Research And Education Institute, Inc. Bone reconstruction
AU632273B2 (en) 1988-03-09 1992-12-24 Terumo Kabushiki Kaisha Medical material permitting cells to enter thereinto and artificial skin
US5350583A (en) 1988-03-09 1994-09-27 Terumo Kabushiki Kaisha Cell-penetrable medical material and artificial skin
US5201745A (en) 1988-03-15 1993-04-13 Imedex Visceral surgery patch
FR2628634B1 (fr) 1988-03-15 1990-07-13 Imedex Patch de chirurgie viscerale
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US4948540A (en) 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material
US5800541A (en) 1988-11-21 1998-09-01 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5304595A (en) 1988-11-21 1994-04-19 Collagen Corporation Collagen-polymer conjugates
US5614587A (en) 1988-11-21 1997-03-25 Collagen Corporation Collagen-based bioadhesive compositions
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5306500A (en) 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
CA2004740A1 (en) 1988-12-07 1990-06-07 Cary Linsky Low molecular weight heparin, heparinoid and hexuronyl hexosaminoglycan sulfate containing adhesion prevention barrier and process
US5171273A (en) 1989-01-13 1992-12-15 University Of Medicine And Dentistry Of New Jersey Synthetic collagen orthopaedic structures such as grafts, tendons and other structures
FR2641692A1 (fr) 1989-01-17 1990-07-20 Nippon Zeon Co Bouchon de fermeture d'une breche pour application medicale et dispositif pour bouchon de fermeture l'utilisant
FR2646343B1 (fr) 1989-04-27 1991-12-20 Gazielly Dominique Dispositif de renfort et de soutien de la coiffe des rotateurs d'une articulation d'epaule d'individu
US5441508A (en) 1989-04-27 1995-08-15 Gazielly; Dominique Reinforcement and supporting device for the rotator cuff of a shoulder joint of a person
US5308663A (en) * 1989-06-20 1994-05-03 Kanai Juyo Kogyo Company Limited Biodegradable nonwoven fabric and its molding vessel
JPH0332677A (ja) 1989-06-30 1991-02-13 Yoshihiko Shimizu 起炎性および凝血性付与静脈閉塞材
US5196185A (en) 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
IL95429A (en) 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
US5201764A (en) 1990-02-28 1993-04-13 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US5256418A (en) 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
DK0526550T3 (da) 1990-04-24 1998-08-31 Ortec International Inc Kompositækvivalent til levende hud
US5141515A (en) 1990-10-11 1992-08-25 Eberbach Mark A Apparatus and methods for repairing hernias
US5116357A (en) 1990-10-11 1992-05-26 Eberbach Mark A Hernia plug and introducer apparatus
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
AU652022B2 (en) 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5749895A (en) 1991-02-13 1998-05-12 Fusion Medical Technologies, Inc. Method for bonding or fusion of biological tissue and material
US5690675A (en) 1991-02-13 1997-11-25 Fusion Medical Technologies, Inc. Methods for sealing of staples and other fasteners in tissue
WO1992015262A1 (en) 1991-03-06 1992-09-17 Aircast, Inc. Injection-molded orthopedic device and method
US5254133A (en) 1991-04-24 1993-10-19 Seid Arnold S Surgical implantation device and related method of use
WO1992019195A1 (en) 1991-04-25 1992-11-12 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5785983A (en) 1991-05-23 1998-07-28 Euroresearch Srl Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
FR2679778B1 (fr) 1991-08-02 1995-07-07 Coletica Utilisation de collagene reticule par un agent de reticulation pour la fabrication d'une membrane suturable, biocompatible, a resorption lente, ainsi qu'une telle membrane.
US5282829A (en) 1991-08-15 1994-02-01 United States Surgical Corporation Hollow body implants
CA2082090C (en) 1991-11-05 2004-04-27 Jack Fagan Improved occluder for repair of cardiac and vascular defects
US5258000A (en) 1991-11-25 1993-11-02 Cook Incorporated Tissue aperture repair device
DK168419B1 (da) 1991-11-25 1994-03-28 Cook Inc A Cook Group Company Støtteindretning for bugvæg og apparat til indføring heraf
EP0544485B1 (de) 1991-11-25 1995-03-08 Cook Incorporated Vorrichtung zum Wiederherstellen einer Gewebeöffnung
US5439467A (en) 1991-12-03 1995-08-08 Vesica Medical, Inc. Suture passer
US5147374A (en) 1991-12-05 1992-09-15 Alfredo Fernandez Prosthetic mesh patch for hernia repair
WO1993010731A1 (en) 1991-12-06 1993-06-10 Kensey Nash Corporation Pads, methods of making, and methods of use for wound dressing, surgical reinforcement and hemostasis promotion
US5176692A (en) 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
IT1254170B (it) 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
US5376376A (en) 1992-01-13 1994-12-27 Li; Shu-Tung Resorbable vascular wound dressings
USRE36370E (en) 1992-01-13 1999-11-02 Li; Shu-Tung Resorbable vascular wound dressings
EP0623003B1 (de) 1992-01-21 1999-03-31 Regents Of The University Of Minnesota Verschlusseinrichtung eines septumschadens
FR2686612B1 (fr) 1992-01-24 1994-04-08 Fournier Sca Laboratoires Procede de preparation de fibres de collagene.
CA2117379C (en) 1992-02-14 1999-11-16 Kypriacos A. Athanasiou Multi-phase bioerodible implant/carrier and method of manufacturing and using same
CA2090000A1 (en) 1992-02-24 1993-08-25 H. Jonathan Tovey Articulating mesh deployment apparatus
US5480644A (en) 1992-02-28 1996-01-02 Jsf Consultants Ltd. Use of injectable biomaterials for the repair and augmentation of the anal sphincters
FR2688222B1 (fr) 1992-03-03 1995-05-19 Univ Picardie Composes polymeres de l'acide glucuronique, procede de preparation et utilisation notamment en tant que moyens gelifiants, epaississants, hydratants, stabilisants, chelatants ou floculants.
WO1993017635A1 (en) 1992-03-04 1993-09-16 C.R. Bard, Inc. Composite prosthesis and method for limiting the incidence of postoperative adhesions
US5217493A (en) 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
GB9206504D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges as wound implants
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
IL105529A0 (en) 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
US5456711A (en) 1992-05-15 1995-10-10 Intervascular Inc. Warp knitted carotid patch having finished selvedged edges
US5766246A (en) 1992-05-20 1998-06-16 C. R. Bard, Inc. Implantable prosthesis and method and apparatus for loading and delivering an implantable prothesis
US6312442B1 (en) 1992-06-02 2001-11-06 General Surgical Innovations, Inc. Method for developing an anatomic space for laparoscopic hernia repair
US5428022A (en) 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen
US5339657A (en) 1992-09-01 1994-08-23 Mcmurray Fabrics, Inc. Net having different size openings and method of making
AU4926193A (en) 1992-09-21 1994-04-12 Vitaphore Corporation Embolization plugs for blood vessels
CZ281454B6 (cs) 1992-11-23 1996-10-16 Milan Mudr. Csc. Krajíček Pomůcka pro nechirurgické uzavírání otvoru ve stěně cévy
US5743917A (en) 1993-01-13 1998-04-28 Saxon; Allen Prosthesis for the repair of soft tissue defects
CA2114282A1 (en) 1993-01-28 1994-07-29 Lothar Schilder Multi-layered implant
US6653450B1 (en) 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
US5667839A (en) 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
US5356432B1 (en) 1993-02-05 1997-02-04 Bard Inc C R Implantable mesh prosthesis and method for repairing muscle or tissue wall defects
US5368602A (en) 1993-02-11 1994-11-29 De La Torre; Roger A. Surgical mesh with semi-rigid border members
US5433996A (en) 1993-02-18 1995-07-18 W. L. Gore & Associates, Inc. Laminated patch tissue repair sheet material
ES2125310T3 (es) 1993-02-18 1999-03-01 Lubomyr Ihor Kuzmak Banda gastrica ajustable para laparoscopia.
US6001895A (en) 1993-03-22 1999-12-14 Johnson & Johnson Medical, Inc. Composite surgical material
US6015844A (en) 1993-03-22 2000-01-18 Johnson & Johnson Medical, Inc. Composite surgical material
US5565210A (en) 1993-03-22 1996-10-15 Johnson & Johnson Medical, Inc. Bioabsorbable wound implant materials
US5942278A (en) 1993-03-31 1999-08-24 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
GB9306812D0 (en) 1993-04-01 1993-05-26 Vascutek Ltd Textile prostheses
FR2704139B1 (fr) 1993-04-23 1995-08-04 Jean Claude Sgro Ensemble prothetique en materiau textile.
DE4316673C1 (de) 1993-05-12 1995-01-12 Ethicon Gmbh Flexibles Implantat
US5607590A (en) 1993-08-06 1997-03-04 Shimizu; Yasuhiko Material for medical use and process for preparing same
JP3542170B2 (ja) 1993-08-06 2004-07-14 株式会社アムニオテック 医用材料及びその製造方法
US5487895A (en) 1993-08-13 1996-01-30 Vitaphore Corporation Method for forming controlled release polymeric substrate
FR2709947B1 (fr) 1993-09-13 1995-11-10 Bard Sa Laboratoires Filet prothétique galbé et son procédé de fabrication.
GB2281861B (en) 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
DE69426414T2 (de) 1993-09-24 2001-05-03 Takiron Co. Ltd., Osaka Implantatmaterial
GB2282328B (en) 1993-09-29 1997-10-08 Johnson & Johnson Medical Absorbable structures for ligament and tendon repair
US5686115A (en) 1993-12-01 1997-11-11 Marine Polymer Technologies, Inc. Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
FR2715309B1 (fr) 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
FR2715405B1 (fr) 1994-01-24 1996-04-05 Imedex Procédé pour l'élimination des prions dans des collagènes et collagènes ainsi obtenus.
US5441491A (en) 1994-02-04 1995-08-15 Verschoor; Jacob Method and composition for treating biopsy wounds
US6334872B1 (en) 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
US6113623A (en) 1994-04-20 2000-09-05 Cabinet Beau De Lomenie Prosthetic device and method for eventration repair
US20030086975A1 (en) 2001-11-08 2003-05-08 Timothy Ringeisen Method for making a porous Polymeric material
US5425740A (en) 1994-05-17 1995-06-20 Hutchinson, Jr.; William B. Endoscopic hernia repair clip and method
US5601571A (en) 1994-05-17 1997-02-11 Moss; Gerald Surgical fastener implantation device
FR2720266B1 (fr) 1994-05-27 1996-12-20 Cogent Sarl Tissu prothétique.
IL110367A (en) 1994-07-19 2007-05-15 Colbar Lifescience Ltd Collagen-based matrix
GB9415125D0 (en) 1994-07-27 1994-09-14 Notaras Mitchell J Surgical product and its use
US5681568A (en) 1994-08-19 1997-10-28 Cambridge Neuroscience, Inc. Device for delivery of substances and methods of use thereof
US5899909A (en) 1994-08-30 1999-05-04 Medscand Medical Ab Surgical instrument for treating female urinary incontinence
US5931165A (en) 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
JP2987064B2 (ja) 1994-09-12 1999-12-06 グンゼ株式会社 人工硬膜
FR2724563A1 (fr) 1994-09-15 1996-03-22 Coletica Utilisation de membranes collageniques comme protheses de regeneration peritoneale
JP2858087B2 (ja) 1994-09-19 1999-02-17 グンゼ株式会社 組織培養用基材及び組織培養法
JPH08196538A (ja) 1994-09-26 1996-08-06 Ethicon Inc エラストマー部材を有する外科用の組織付着器具および該組織へ外科用のメッシュを張り付ける方法
US5916225A (en) 1994-09-29 1999-06-29 Surgical Sense, Inc. Hernia mesh patch
US5769864A (en) 1994-09-29 1998-06-23 Surgical Sense, Inc. Hernia mesh patch
US5634931A (en) 1994-09-29 1997-06-03 Surgical Sense, Inc. Hernia mesh patches and methods of their use
US6290708B1 (en) 1994-09-29 2001-09-18 Bard Asdi Inc. Hernia mesh patch with seal stiffener
US6280453B1 (en) 1994-09-29 2001-08-28 Bard Asdi Inc. Hernia mesh patch with stiffener line segment
US6171318B1 (en) 1994-09-29 2001-01-09 Bard Asdi Inc. Hernia mesh patch with stiffening layer
US6176863B1 (en) 1994-09-29 2001-01-23 Bard Asdi Inc. Hernia mesh patch with I-shaped filament
US6174320B1 (en) 1994-09-29 2001-01-16 Bard Asdi Inc. Hernia mesh patch with slit
US6294202B1 (en) 1994-10-06 2001-09-25 Genzyme Corporation Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
US6063396A (en) 1994-10-26 2000-05-16 Houston Biotechnology Incorporated Methods and compositions for the modulation of cell proliferation and wound healing
IT1275080B (it) 1994-11-09 1997-07-30 Gabriele Valenti Protesi dinamica in duplice strato per il trattamento chirurgico dell'ernia inguinale
BE1008955A3 (fr) 1994-11-14 1996-10-01 Univ Catholique Louvain Procede d'obtention de biomateriaux et produits obtenus.
US5891558A (en) 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5709934A (en) 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
FR2728776B1 (fr) 1994-12-30 1997-07-18 Cogent Sarl Element prothetique pour le traitement des hernies de l'aine, notamment par voie coelioscopique
US6080194A (en) 1995-02-10 2000-06-27 The Hospital For Joint Disease Orthopaedic Institute Multi-stage collagen-based template or implant for use in the repair of cartilage lesions
FR2730406B1 (fr) 1995-02-13 1997-08-14 Medinov Sa Dispositif d'allongement perfectionne d'os longs
GB9721585D0 (en) 1997-10-10 1997-12-10 Geistlich Soehne Ag Chemical product
JP3543869B2 (ja) 1995-03-07 2004-07-21 株式会社メニコン 培養皮膚およびその製造法
AUPN174495A0 (en) 1995-03-15 1995-04-06 Ketharanathan, Vettivetpillai Surgical prostheses
US20020095218A1 (en) 1996-03-12 2002-07-18 Carr Robert M. Tissue repair fabric
US5676967A (en) 1995-04-18 1997-10-14 Brennen Medical, Inc. Mesh matrix wound dressing
US5911731A (en) 1995-04-20 1999-06-15 Target Therapeutics, Inc. Anatomically shaped vasoocclusive devices
US5900479A (en) * 1995-05-05 1999-05-04 Virginia Tech Intellectual Properties, Inc. Chitin-based coatings
GB2301362B (en) 1995-05-30 1999-01-06 Johnson & Johnson Medical Absorbable implant materials having controlled porosity
FR2735015B1 (fr) 1995-06-12 1998-02-13 Microval Prothese interne sous forme d'un support textile ou autre et son appareil d'insertion par voie coelioscopique
EP0913124B1 (de) 1995-06-30 2003-11-26 Boston Scientific Limited Ausdehnungswiderstandsfähige vaso-okklusive Spirale
US5569273A (en) 1995-07-13 1996-10-29 C. R. Bard, Inc. Surgical mesh fabric
US5771716A (en) 1995-09-18 1998-06-30 Schlussel; Edward Warp-knitted loop net fabric
GB2306110A (en) 1995-09-20 1997-04-30 Olusola Olumide Akindele Oni Suture Anchor Installation Device
US5665391A (en) 1995-10-12 1997-09-09 Spectral Diagnostics Inc. Cultured, full-thickness integument substitutes based on three-dimensional matrix membranes
JPH09137380A (ja) 1995-11-10 1997-05-27 Toray Ind Inc 多層構造編地
DE19544162C1 (de) 1995-11-17 1997-04-24 Ethicon Gmbh Implantat zur Suspension der Harnblase bei Harninkontinenz der Frau
CA2164262A1 (en) 1995-12-01 1997-06-02 Charles J. Doillon Biostable porous material comprising composite biopolymers
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
BR9707223A (pt) 1996-01-29 1999-12-28 Charles Doillon Produtos de colágeno e derivados de colágeno isentos de prìon e implantes para múltiplas aplicações biomédicas ; métodos de obtenção dos mesmos
FR2744906B1 (fr) 1996-02-21 1998-04-24 Cousin Biotech Plaque de refection de hernie
JP2822174B2 (ja) * 1996-03-01 1998-11-11 オーミケンシ株式会社 キチンキトサン繊維及び構造体の製造法
WO1997035533A1 (en) 1996-03-25 1997-10-02 Enrico Nicolo Surgical mesh prosthetic material and methods of use
DE19613730C2 (de) 1996-03-26 2002-08-14 Ethicon Gmbh Flächiges Implantat zum Verstärken oder Verschließen von Körpergewebe
US5876444A (en) 1996-04-01 1999-03-02 Lai; Wen-Fu Reconstituted collagen template and the process to prepare the same
US5792154A (en) 1996-04-10 1998-08-11 Target Therapeutics, Inc. Soft-ended fibered micro vaso-occlusive devices
US6132765A (en) 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
DE19718903A1 (de) 1996-06-12 1997-12-18 Rainer Otto Cerclage-Spannvorrichtung für die Osteosynthese von Knochenfrakturen
US6143037A (en) 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US6500777B1 (en) 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
EP0827724A3 (de) 1996-09-09 1998-05-06 Herniamesh S.r.l. Herniaplastische Prothese mit vorgeformtem Netz aus Polypropylen-Monofilament
FR2754268B1 (fr) 1996-10-07 1998-12-24 Dev Des Utilisations Du Collag Composition adhesive a base de polyaldehyde macromoleculaire et procede de reticulation de collagene ou de gelatine
US5716409A (en) 1996-10-16 1998-02-10 Debbas; Elie Reinforcement sheet for use in surgical repair
FR2754705B1 (fr) 1996-10-18 1998-12-18 Cogent Sarl Prothese anatomique pour la reparation de hernies par voie laparoscopique ou ouverte
TW501934B (en) 1996-11-20 2002-09-11 Tapic Int Co Ltd Collagen material and process for making the same
WO1998024483A2 (en) 1996-12-03 1998-06-11 Osteobiologics, Inc. Biodegradable polymeric film
CA2224366C (en) 1996-12-11 2006-10-31 Ethicon, Inc. Meniscal repair device
AU6021598A (en) 1997-01-09 1998-08-03 Cohesion Technologies, Inc. Methods and apparatuses for making swellable uniformly shaped devices from polymeric materials
US5814328A (en) 1997-01-13 1998-09-29 Gunasekaran; Subramanian Preparation of collagen using papain and a reducing agent
FR2759084B1 (fr) 1997-02-06 1999-10-29 Dev Des Utilisations Du Collag Materiau collagenique utile notamment pour la prevention d'adherences post-operatoires
AU6329598A (en) 1997-02-13 1998-09-08 Boston Scientific Ireland Limited, Barbados Head Office Stabilization sling for use in minimally invasive pelvic surgery
US6039686A (en) 1997-03-18 2000-03-21 Kovac; S. Robert System and a method for the long term cure of recurrent urinary female incontinence
FR2762207B1 (fr) 1997-04-17 1999-07-30 Ethnor Perfectionnements aux protheses sous-cutanees pour plastie mammaire
US5922026A (en) 1997-05-01 1999-07-13 Origin Medsystems, Inc. Surgical method and prosthetic strip therefor
US6120539A (en) 1997-05-01 2000-09-19 C. R. Bard Inc. Prosthetic repair fabric
US5938669A (en) 1997-05-07 1999-08-17 Klasamed S.A. Adjustable gastric banding device for contracting a patient's stomach
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
DE19751733A1 (de) 1997-06-09 1998-12-10 Arnold Dipl Ing Dr Med Pier Laparoskopisch einsetzbares Magenband
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6066776A (en) 1997-07-16 2000-05-23 Atrium Medical Corporation Self-forming prosthesis for repair of soft tissue defects
US5980564A (en) 1997-08-01 1999-11-09 Schneider (Usa) Inc. Bioabsorbable implantable endoprosthesis with reservoir
FR2766698B1 (fr) 1997-08-01 1999-11-05 Cogent Sarl Tissu prothetique tridimensionnel ajoure
FR2766716B1 (fr) 1997-08-01 2000-02-18 Cogent Sarl Prothese composite pour la prevention des adherences post-chirurgicales et son procede d'obtention
FR2766717B1 (fr) 1997-08-01 2000-06-09 Cogent Sarl Prothese composite pour la prevention des adherences post-chirurgicales et son procede d'obtention
US6042592A (en) 1997-08-04 2000-03-28 Meadox Medicals, Inc. Thin soft tissue support mesh
ATE220564T1 (de) 1997-08-14 2002-08-15 Sulzer Innotec Ag Zusammensetzung und vorrichtung zur reparatur von knorpelgewebe in vivo bestehend aus nanokapseln mit osteoinduktiven und/oder chondroinduktiven faktoren
US6511958B1 (en) 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
US6241768B1 (en) 1997-08-27 2001-06-05 Ethicon, Inc. Prosthetic device for the repair of a hernia
FR2767671B1 (fr) 1997-08-27 1999-11-26 Ethnor Dispositif obturateur prothetique pour l'obturation de canaux herniaires
ATE306935T1 (de) 1997-09-16 2005-11-15 Integra Lifesciences Corp Zusammensetzung zur förderung des wachstums von duralem oder meningealem gewebe enthaltend kollagen
US5997895A (en) 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
GB2329840C (en) 1997-10-03 2007-10-05 Johnson & Johnson Medical Biopolymer sponge tubes
US6090116A (en) 1997-10-03 2000-07-18 D'aversa; Margaret M. Knitted surgical mesh
FR2769825B1 (fr) 1997-10-22 1999-12-03 Cogent Sarl Implant prothetique obturateur de canal anatomique, et ensemble d'obturation le comportant
CA2307567C (en) 1997-10-31 2009-01-20 Children's Medical Center Corporation Polymer matrix/cell construct for bladder reconstruction
FR2771623B1 (fr) 1997-11-28 2000-02-18 Richard Cancel Dispositif pour la mise en place d'une prothese dans le traitement des hernies de l'aine par voie coelioscopique
US6008292A (en) 1997-12-02 1999-12-28 Baxter International Inc. Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials
FR2773057B1 (fr) 1997-12-29 2001-01-05 Braun Celsa Sa Ensemble medical pour traiter une affection d'un conduit anatomique
FR2774277B1 (fr) 1998-02-03 2000-06-30 Cogent Sarl Agrafe de fixation prothetique resorbable
US6179872B1 (en) 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
US6410044B1 (en) 1998-03-19 2002-06-25 Surmodics, Inc. Crosslinkable macromers
US6319264B1 (en) 1998-04-03 2001-11-20 Bionx Implants Oy Hernia mesh
US6637437B1 (en) 1998-04-08 2003-10-28 Johns Hopkins University Cell-culture and polymer constructs
US5910149A (en) 1998-04-29 1999-06-08 Kuzmak; Lubomyr I. Non-slipping gastric band
US6056970A (en) 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
US6197934B1 (en) 1998-05-22 2001-03-06 Collagenesis, Inc. Compound delivery using rapidly dissolving collagen film
WO1999064081A1 (en) 1998-06-08 1999-12-16 Ferris Corporation Analgesic and antinociceptive methods
FR2779937B1 (fr) 1998-06-23 2000-08-11 Sofradim Production Tissu prothetique isoelastique ajoure
DE19832634A1 (de) 1998-07-09 2000-01-13 Ethicon Endo Surgery Europe Mehrschichtiges flächiges Implantat
US6669735B1 (en) 1998-07-31 2003-12-30 Davol, Inc. Prosthesis for surgical treatment of hernia
FR2783429B1 (fr) 1998-09-18 2002-04-12 Imedex Biomateriaux Materiau collagenique bicomposite,son procede d'obtention et ses applications therapeutiques
US20030225355A1 (en) 1998-10-01 2003-12-04 Butler Charles E. Composite material for wound repair
KR20010033116A (ko) 1998-10-14 2001-04-25 마츠모토 고이치 입체구조형상 네트와 이 네트를 이용한 복합구조재
FR2786400B1 (fr) 1998-11-30 2002-05-10 Imedex Biomateriaux Procede de preparation d'un materiau collagenique a vitesse de biodegradation in vivo controlee et materiaux obtenus
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
EP1022031B1 (de) 1999-01-21 2005-03-23 Nipro Corporation Nähbare Membran zur Adhäsionsverhinderung
WO2000047129A2 (en) 1999-02-11 2000-08-17 The General Hospital Corporation Microfabricated membranes and matrices
IL129032A (en) 1999-03-17 2006-12-31 Moshe Dudai Stomach strap
DE19912648A1 (de) 1999-03-20 2000-09-21 Aesculap Ag & Co Kg Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie
US6287316B1 (en) 1999-03-26 2001-09-11 Ethicon, Inc. Knitted surgical mesh
US6391333B1 (en) 1999-04-14 2002-05-21 Collagen Matrix, Inc. Oriented biopolymeric membrane
EP1052319A1 (de) 1999-05-03 2000-11-15 Malden Mills Industries, Inc. Dreidimensionale Verbundstoffwaren
US6258124B1 (en) 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
US6656206B2 (en) 1999-05-13 2003-12-02 Cardia, Inc. Occlusion device with non-thrombogenic properties
US6383201B1 (en) 1999-05-14 2002-05-07 Tennison S. Dong Surgical prosthesis for repairing a hernia
FR2801313A1 (fr) 1999-05-19 2001-05-25 Coletica Produit collagenique contenant du collagene d'origine marine a faible odeur et de preference a proprietes mecaniques ameliorees, ainsi que son utilisation sous forme de compositions ou de produits cosmetiques ou pharmaceutiques
ATE334639T1 (de) 1999-06-08 2006-08-15 Ethicon Inc Chirurgische strickgewebe
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6245080B1 (en) 1999-07-13 2001-06-12 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
DE60015778T2 (de) 1999-07-15 2005-11-24 Biotap A/S Implantat
ES2242631T3 (es) 1999-07-21 2005-11-16 Imedex Biomateriaux Espuma de una proteina adhesiva para usos quirurgicos y/o terapeuticos.
WO2001008594A1 (en) 1999-07-28 2001-02-08 C.R. Bard, Inc. Hernia prosthesis
DE19942611C1 (de) 1999-08-31 2001-07-05 Ethicon Gmbh Verstärktes flächiges Implantat
US6312474B1 (en) 1999-09-15 2001-11-06 Bio-Vascular, Inc. Resorbable implant materials
US6221109B1 (en) 1999-09-15 2001-04-24 Ed. Geistlich Söhne AG fur Chemische Industrie Method of protecting spinal area
US6592625B2 (en) 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
DE19954166A1 (de) 1999-11-10 2001-05-17 Inst Textil & Faserforschung Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie
EP1267762A4 (de) 1999-11-15 2005-05-25 Texas A & M Univ Sys In-situ geformter wundverband
US6302897B1 (en) 1999-11-19 2001-10-16 Ethicon, Inc. Device for deploying medical textiles
US6482240B1 (en) 1999-12-07 2002-11-19 Ed. Geistlich Soehne Ag Fur Chemische Industrie Method of making a collagen membrane from porcine skin
US6306079B1 (en) 1999-12-07 2001-10-23 Arnaldo F. Trabucco Mesh pubovaginal sling
WO2001044551A1 (en) 1999-12-16 2001-06-21 Asahi Doken Kabushiki Kaisha Three-dimensional maquisette style knitted fabric
US6623963B1 (en) 1999-12-20 2003-09-23 Verigen Ag Cellular matrix
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
DE19964081B4 (de) 1999-12-29 2005-06-30 Ethicon Gmbh Streifenartiges Implantat und chirurgisches Greifinstrument
GB2358637A (en) * 2000-01-27 2001-08-01 Btg Int Ltd Chitosan condensation products with a bisulphite addition compound
US6436030B2 (en) 2000-01-31 2002-08-20 Om P. Rehil Hiatal hernia repair patch and method for using the same
US6627785B1 (en) * 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
ATE289828T1 (de) 2000-03-09 2005-03-15 Syntacoll Ag Mehrschicht-kollagenmatrix zur geweberekonstruktion
US6425924B1 (en) 2000-03-31 2002-07-30 Ethicon, Inc. Hernia repair prosthesis
US6723335B1 (en) 2000-04-07 2004-04-20 Jeffrey William Moehlenbruck Methods and compositions for treating intervertebral disc degeneration
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
DE10019604C2 (de) 2000-04-20 2002-06-27 Ethicon Gmbh Implantat
FR2807936B1 (fr) 2000-04-20 2002-08-02 Sofradim Production Renfort de paroi abdominale pour le traitement des hernies inguinales par voie anterieure sans tension
FR2807937B1 (fr) 2000-04-20 2002-08-02 Sofradim Production Tricot prothetique agrippant, son procede de fabrication et implant de renfort pour le traitement des deficits parietaux
IT1318499B1 (it) 2000-05-05 2003-08-25 Angiologica B M S R L Rete anatomica a doppio strato per chirurgia.
US6485503B2 (en) 2000-05-19 2002-11-26 Coapt Systems, Inc. Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device
US6645226B1 (en) 2000-05-19 2003-11-11 Coapt Systems, Inc. Multi-point tension distribution system device and method of tissue approximation using that device to improve wound healing
DE60114508T2 (de) 2000-05-22 2006-07-20 Delta Tooling Co. Ltd. Netz zur Weiterverarbeitung
US6974679B2 (en) 2000-05-26 2005-12-13 Coletica Support with collagen base for tissue engineering and manufacture of biomaterials
US6790454B1 (en) 2000-05-26 2004-09-14 Coletica Processes for the preparation of novel collagen-based supports for tissue engineering, and biomaterials obtained
FR2809412A1 (fr) 2000-05-26 2001-11-30 Coletica Utilisation de collagene d'origine aquatique pour la realisation de supports destines a l'ingenierie tissulaire, et supports et biomateriaux obtenus
US6610006B1 (en) 2000-07-25 2003-08-26 C. R. Bard, Inc. Implantable prosthesis
US8366787B2 (en) 2000-08-04 2013-02-05 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
EP1313372B1 (de) * 2000-08-22 2005-06-01 Chitoproducts Limited Herstellung von gegenständen mit kontakt-bioziden eigenschaften
AU2001288458A1 (en) 2000-08-28 2002-03-13 Collagenesis, Inc. Methods for processing animal tissues
US6773723B1 (en) 2000-08-30 2004-08-10 Depuy Acromed, Inc. Collagen/polysaccharide bilayer matrix
AU2001286701A1 (en) 2000-08-31 2002-03-13 Genzyme Biosurgery Corporation Hyaluronan-based antiadhesion compositions, their preparation and use
DE10043151A1 (de) 2000-08-31 2002-03-28 Peter Steinruecke Knochenzement mit antimikrobieller Wirksamkeit
DE10043396C1 (de) 2000-09-04 2002-06-20 Ethicon Gmbh Flexibles Implantat
US7662169B2 (en) 2000-09-05 2010-02-16 Wittmann Dietmar H Prosthesis and method for lowering abdominal pressure
US6746458B1 (en) 2000-09-07 2004-06-08 William G. Cloud Mesh material to repair hernias
US7025063B2 (en) 2000-09-07 2006-04-11 Ams Research Corporation Coated sling material
US7404819B1 (en) 2000-09-14 2008-07-29 C.R. Bard, Inc. Implantable prosthesis
US20020084178A1 (en) 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
US6852330B2 (en) 2000-12-21 2005-02-08 Depuy Mitek, Inc. Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CA2365376C (en) 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6599323B2 (en) 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US7192604B2 (en) 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
IT249353Y1 (it) 2000-12-28 2003-04-14 Soveta S R L Rete per uso chirurgico.
US6500464B2 (en) 2000-12-28 2002-12-31 Ortec International, Inc. Bilayered collagen construct
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US7229453B2 (en) 2001-01-23 2007-06-12 Ams Research Corporation Pelvic floor implant system and method of assembly
US7098315B2 (en) 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
US6783554B2 (en) 2001-02-20 2004-08-31 Atrium Medical Corporation Pile mesh prosthesis
GB0108088D0 (en) 2001-03-30 2001-05-23 Browning Healthcare Ltd Surgical implant
US7226611B2 (en) 2001-04-02 2007-06-05 Yaizu Suisankagaku Industry Co., Ltd. Glycosaminoglycan/collagen complexes and use thereof
US6719795B1 (en) 2001-04-25 2004-04-13 Macropore Biosurgery, Inc. Resorbable posterior spinal fusion system
US6575988B2 (en) 2001-05-15 2003-06-10 Ethicon, Inc. Deployment apparatus for supple surgical materials
US6616685B2 (en) 2001-06-06 2003-09-09 Ethicon, Inc. Hernia repair device
US7371403B2 (en) * 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US6712859B2 (en) 2001-06-28 2004-03-30 Ethicon, Inc. Hernia repair prosthesis and methods for making same
US8877233B2 (en) 2001-06-29 2014-11-04 Cook Biotech Incorporated Porous sponge matrix medical devices and methods
US6540773B2 (en) 2001-07-03 2003-04-01 Scimed Life Systems, Inc. Low profile, high stretch knit prosthetic device
US6554855B1 (en) 2001-07-03 2003-04-29 Scimed Life Systems, Inc. Low profile, high stretch, low dilation knit prosthetic device
DE10135275A1 (de) 2001-07-13 2003-01-30 Jotec Gmbh Implantat und Verfahren zu seiner Herstellung
US6613348B1 (en) 2001-07-31 2003-09-02 Manoj K. Jain Process of controlling absorbency in collagen flakes
FR2829922B1 (fr) 2001-09-21 2004-06-18 Sofradim Production Implant complet et universel pour la reparation des hernies par voie anterieure
US7087065B2 (en) 2001-10-04 2006-08-08 Ethicon, Inc. Mesh for pelvic floor repair
FR2830434B1 (fr) 2001-10-05 2004-01-02 Sofradim Production Renfort de paroi en tricot tridimensionnel et ajoure
US6800082B2 (en) 2001-10-19 2004-10-05 Ethicon, Inc. Absorbable mesh device
DE10152407A1 (de) 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten
US20030091851A1 (en) * 2001-10-31 2003-05-15 National University Of Singapore Method of preparing chitin films
DE10155842A1 (de) 2001-11-14 2003-05-28 Ethicon Gmbh Flächiges Implantat
US6790213B2 (en) 2002-01-07 2004-09-14 C.R. Bard, Inc. Implantable prosthesis
CA2476653C (en) 2002-02-21 2009-01-27 Encelle, Inc. Cross-linked bioactive hydrogel matrices
US6755868B2 (en) 2002-03-22 2004-06-29 Ethicon, Inc. Hernia repair device
DE10221320A1 (de) 2002-05-07 2003-11-27 Gfe Medizintechnik Gmbh Flächiges Implantat aus textilem Fadenmaterial, insbesondere Herniennetz
US6736854B2 (en) 2002-05-10 2004-05-18 C. R. Bard, Inc. Prosthetic repair fabric with erosion resistant edge
US6736823B2 (en) 2002-05-10 2004-05-18 C.R. Bard, Inc. Prosthetic repair fabric
US7011688B2 (en) 2002-05-10 2006-03-14 C.R. Bard, Inc. Prosthetic repair fabric
WO2003101501A1 (en) 2002-06-03 2003-12-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem A multi-layer collagenic article useful for wounds healing
DE60330860D1 (de) 2002-06-12 2010-02-25 Boston Scient Ltd The Corporat Medizinische schlinge
US20050137512A1 (en) 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040101546A1 (en) 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
AU2003253106A1 (en) 2002-07-04 2004-01-23 Gyne Ideas Ltd Medical implant
DE10231975A1 (de) 2002-07-15 2004-02-05 Serag-Wiessner Kg Implantierbares textiles Flächengebilde
GB2390856A (en) 2002-07-16 2004-01-21 Alcare Co Ltd Warp-knit stretch fabric for medical use
AU2003249310A1 (en) 2002-07-17 2004-02-02 Proxy Biomedical Limited Soft tissue implants and methods for making same
US7101381B2 (en) 2002-08-02 2006-09-05 C.R. Bard, Inc. Implantable prosthesis
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8142515B2 (en) 2002-11-04 2012-03-27 Sofradim Production Prosthesis for reinforcement of tissue structures
JP2006508773A (ja) 2002-12-05 2006-03-16 株式会社カルディオ 生体適合性組織片およびその利用
AU2003289246B2 (en) 2002-12-16 2007-10-04 Gunze Limited Medical film
JP2007500071A (ja) 2003-02-11 2007-01-11 シー・アール・バード・インコーポレーテッド 埋込型補綴物およびその使用方法
EP1605862A4 (de) 2003-02-28 2008-09-03 Fibrogen Inc Kollagen-zusammensetzungen und biomaterialien
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
EP1618856B1 (de) 2003-03-31 2011-06-08 Teijin Limited Verbund aus trägersubstrat und kollagen und verfahren zur herstellung eines trägersubstrats und verbunds
US20060135921A1 (en) 2003-04-04 2006-06-22 Wiercinski Robert A Porous particulate collagen sponges
DE10318801A1 (de) 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Flächiges Implantat und seine Verwendung in der Chirurgie
DE20306635U1 (de) 2003-04-28 2003-06-26 GfE Medizintechnik GmbH, 90431 Nürnberg Chirurgische Flächeneinlage
US6949625B2 (en) 2003-05-12 2005-09-27 Khorionyx Injectable implant of insoluble globin
ES2220213B1 (es) 2003-05-20 2006-01-16 Juan Manuel Bellon Caneiro Protesis compuesta de doble malla que corrige defectos de pared abdominal, e impide la formacion de adherencias en la interfaz peritoneal.
AU2004245086B2 (en) 2003-06-05 2008-06-26 Baxter Healthcare S.A. Compositions for repairing and regenerating human dura mater
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
EP1641499B1 (de) * 2003-06-20 2012-12-19 Systagenix Wound Management IP Co. BV. Antioxidatives wundverbandmaterial
US6974862B2 (en) 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
US7931695B2 (en) 2003-07-15 2011-04-26 Kensey Nash Corporation Compliant osteosynthesis fixation plate
NL1023926C2 (nl) 2003-07-15 2005-01-18 Univ Groningen Prothese op basis van een met vezels versterkte hydrogel en werkwijze voor het vervaardigen van de prothese en de toepassing hiervan.
US20060179465A1 (en) 2003-07-24 2006-08-10 Koninklijke Philips Electroncs N.V. Handling feature availability in a broadcast
FI120333B (fi) 2003-08-20 2009-09-30 Bioretec Oy Huokoinen lääketieteellinen väline ja menetelmä sen valmistamiseksi
FR2859624B1 (fr) 2003-09-16 2005-12-02 Sofradim Production Tricot prothetique a proprietes variables
US7393319B2 (en) 2003-10-14 2008-07-01 Caldera Medical, Inc. Implantable sling having bladder support
US20050085924A1 (en) 2003-10-17 2005-04-21 Darois Roger E. Tissue infiltratable prosthetic device incorporating an antimicrobial substance
DE10353756A1 (de) 2003-11-17 2005-06-30 Bio-Gate Bioinnovative Materials Gmbh Schichtmaterial
US20050113849A1 (en) 2003-11-26 2005-05-26 Nicholas Popadiuk Prosthetic repair device
FR2863277B1 (fr) 2003-12-05 2006-06-16 Analytic Biosurgical Solutions Tricot chaine a usage chirurgical
FR2863502B1 (fr) 2003-12-15 2007-03-16 Cousin Biotech Implant textile adhesif de refection parietale
US20050142161A1 (en) 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
US20050148963A1 (en) 2004-01-05 2005-07-07 Brennan H. G. Bioabsorbable surgical sponge
US20050175659A1 (en) 2004-02-09 2005-08-11 Macomber Laurel R. Collagen device and method of preparing the same
WO2005079335A2 (en) 2004-02-12 2005-09-01 The University Of Akron Mechanically attached medical device coatings
ES2546393T3 (es) 2004-04-20 2015-09-23 Genzyme Corporation Implante quirúrgico tipo malla
US7682381B2 (en) 2004-04-23 2010-03-23 Boston Scientific Scimed, Inc. Composite medical textile material and implantable devices made therefrom
US20050267521A1 (en) 2004-05-13 2005-12-01 St. Jude Medical Puerto Rico B.V. Collagen sponge for arterial sealing
GB0411360D0 (en) 2004-05-21 2004-06-23 Mpathy Medical Devices Ltd Implant
US20050288691A1 (en) 2004-06-28 2005-12-29 Leiboff Arnold R Hernia patch
CN100558317C (zh) 2004-07-20 2009-11-11 依威克萨医药公司 脐疝或脐旁疝的修补物
FR2873700B1 (fr) 2004-07-29 2006-11-24 Centre Nat Rech Scient Cnrse Procede d'oxydation controlee de polysaccharides
US8562633B2 (en) 2004-08-02 2013-10-22 W. L. Gore & Associates, Inc. Tissue repair device with a bioabsorbable support member
JP4076525B2 (ja) 2004-08-06 2008-04-16 Ｙｋｋ株式会社 編成面ファスナー
EP1776065B1 (de) 2004-08-13 2012-02-15 Mast Biosurgery AG Chirurgische prothese mit biologisch abbaubaren und nichtabbaubaren regionen
CA2576422C (en) 2004-08-17 2013-10-29 Tyco Healthcare Group Lp Anti-adhesion barrier
US20060039272A1 (en) 2004-08-23 2006-02-23 Divaydeep Sikri Multi-band wideband transmission methods and apparatus having improved user capacity
FR2876020B1 (fr) 2004-10-06 2007-03-09 Sofradim Production Sa Appareil de stockage, distribution et pose d'attaches chirurgicales
IL164591A0 (en) 2004-10-14 2005-12-18 Hernia repair device
EP1674048B1 (de) 2004-12-23 2009-10-21 Novus Scientific Pte. Ltd. Gewebeimplantat zur Verwendung in der Rekonstruktion von Weichgewebedefekten
US7789888B2 (en) 2005-02-14 2010-09-07 Bartee Chad M PTFE composite multi-layer material
DE102005009356A1 (de) 2005-03-01 2006-09-07 Ethicon Gmbh Chirurgisches Implantat
JP2008538300A (ja) 2005-03-22 2008-10-23 タイコ ヘルスケア グループ リミテッド パートナーシップ 生体活性の広く織られたメッシュ
US7556598B2 (en) 2005-04-04 2009-07-07 Boston Scientific Scimed, Inc. Dissolvable protective treatment for an implantable supportive sling
FR2884706B1 (fr) 2005-04-22 2008-04-04 Sofradim Production Sa Tricot prothetique pour implants de soutien
US20060253203A1 (en) 2005-05-03 2006-11-09 Alfredo Alvarado Hernial prosthesis for intraprosthetic fixation
FR2898502B1 (fr) * 2006-03-16 2012-06-15 Sofradim Production Tissu prothetique tridimensionnel a face dense resorbable
FR2889449B1 (fr) 2005-08-05 2011-06-10 Khorionyx Preparations implantables
US20090216338A1 (en) 2005-09-12 2009-08-27 Peter Gingras Soft tissue implants and methods for making same
US7429241B2 (en) 2005-09-29 2008-09-30 Codman & Shurtleff, Inc. Dural graft and method of preparing the same
WO2007047743A2 (en) 2005-10-18 2007-04-26 Cook Biotech Incorporated Medical device with affixation means
WO2007048099A2 (en) 2005-10-18 2007-04-26 Organogenesis, Inc. Antimicrobial collagenous constructs
ES2397381T3 (es) 2006-01-12 2013-03-06 Integra Lifesciences Corporation Producto reparador dural y meníngeo suturable que comprende matriz de colágeno
MX2008010126A (es) 2006-02-08 2010-02-22 Tyrx Pharma Inc Protesis de malla temporalmente rigidizadas.
WO2007109062A2 (en) 2006-03-15 2007-09-27 C.R. Bard, Inc. Implants for the treatment of pelvic floor disorders
US20070237811A1 (en) * 2006-04-10 2007-10-11 Scherr George H Chitosan wound dressing
US20070299538A1 (en) 2006-06-26 2007-12-27 Roeber Peter J Ease of use tissue repair patch
US8709094B2 (en) 2006-06-26 2014-04-29 DePuy Synthes Products, LLC Anti-adhesion sheet
US7544213B2 (en) 2006-09-12 2009-06-09 Adams Jason P Inflatable hernia patch
US7614258B2 (en) 2006-10-19 2009-11-10 C.R. Bard, Inc. Prosthetic repair fabric
IL178867A (en) * 2006-10-26 2010-05-31 Vladimir N Filatov Hemostatic textile material
US7828854B2 (en) 2006-10-31 2010-11-09 Ethicon, Inc. Implantable repair device
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008083394A2 (en) 2007-01-02 2008-07-10 Boston Scientific Scimed, Inc. Reinforced mesh for retropubic implants
US20090192530A1 (en) 2008-01-29 2009-07-30 Insightra Medical, Inc. Fortified mesh for tissue repair
US8079023B2 (en) 2007-03-22 2011-12-13 Microsoft Corporation Typed intermediate language support for existing compilers
US20080255593A1 (en) 2007-04-12 2008-10-16 Pascal St-Germain Prosthetic repair patch with suture retaining structure
US20090036907A1 (en) 2007-07-30 2009-02-05 Yves Bayon Bioresorbable knit
WO2009018128A2 (en) 2007-07-31 2009-02-05 Zimmer, Inc. Joint space interpositional prosthetic device with internal bearing surfaces
US20090036996A1 (en) 2007-08-03 2009-02-05 Roeber Peter J Knit PTFE Articles and Mesh
US20090187197A1 (en) 2007-08-03 2009-07-23 Roeber Peter J Knit PTFE Articles and Mesh
US20090068250A1 (en) 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
ITMI20072011A1 (it) 2007-10-17 2009-04-18 Pipo Llc Procedimento chirurgico per la correzione del cistocele e del rettocele.
FR2924330B1 (fr) 2007-12-03 2009-11-20 Sofradim Production Implant pour hernie parastomiale
CA2708100A1 (en) 2007-12-07 2009-06-18 C. R. Bard, Inc. Implantable prosthesis
US8206632B2 (en) 2007-12-18 2012-06-26 Ethicon, Inc. Methods of making composite prosthetic devices having improved bond strength
US20090163936A1 (en) 2007-12-21 2009-06-25 Chunlin Yang Coated Tissue Engineering Scaffold
US8123817B2 (en) 2007-12-28 2012-02-28 Boston Scientific Scimed, Inc. Meshes of variable construction
FR2929834B1 (fr) 2008-04-11 2011-01-28 Sofradim Production Clip chirurgical pour la fixation et le maintien d'une prothese herniaire
US20090270999A1 (en) 2008-04-24 2009-10-29 Brown Roderick B Patch for endoscopic repair of hernias
US9427297B2 (en) 2008-05-09 2016-08-30 Boston Scientific Scimed, Inc. Surgical meshes with radiopaque coatings
FR2932978B1 (fr) 2008-06-27 2010-06-11 Aspide Medical Prothese herniaire et son procede de fabrication
US9242026B2 (en) * 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US20100104608A1 (en) 2008-09-26 2010-04-29 Tyco Healthcare Group Lp Reactive surgical implant
CA2740597C (en) 2008-10-17 2017-11-21 Sofradim Production Multi-layered surgical patches comprising a first hydrogel precursor and a second hydrogel precursor
WO2010043978A2 (en) 2008-10-17 2010-04-22 Sofradim Production Matrix for tissue repair
AU2009305115B2 (en) 2008-10-17 2014-09-25 Sofradim Production Auto-sealant matrix for tissue repair
US8962006B2 (en) 2008-11-07 2015-02-24 Sofradim Production Composite mesh including a 3D mesh and a non porous film of oxidized cellulose from bacterial cellulose origin
JP5653931B2 (ja) 2008-12-15 2015-01-14 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 補綴デバイスおよびその製作方法
US20120150204A1 (en) 2008-12-15 2012-06-14 Allergan, Inc. Implantable silk prosthetic device and uses thereof
FR2941616B1 (fr) 2009-01-30 2012-06-08 T H T Textile Hi Tec Plaque implantable pour la refection de parois
WO2010088699A2 (en) 2009-02-02 2010-08-05 Biomerix Corporation Composite mesh devices and methods for soft tissue repair
CN102316823B (zh) 2009-02-11 2016-06-08 新加坡南洋理工大学 多层外科用假体
FR2942242B1 (fr) * 2009-02-17 2011-06-03 Laboratoire Tetra Medical Procede d'obtention d'un element longiforme de polysaccharide, notamment un fil de chitosane et fil de polysaccharide obtenu
DE102009015302A1 (de) 2009-03-19 2010-09-23 Aesculap Ag Chirurgisches Implantat, insbesondere zur Versorgung von Hernien
CA2761312C (en) 2009-05-07 2018-07-24 Tyco Healthcare Group Lp Surgical patch cover and method of use
US8784294B2 (en) 2009-06-03 2014-07-22 Boston Scientific Scimed, Inc. Synthetic graft for soft tissue repair
FR2949688B1 (fr) 2009-09-04 2012-08-24 Sofradim Production Tissu avec picots revetu d'une couche microporeuse bioresorbable
FR2949687B1 (fr) 2009-09-04 2011-09-23 Sofradim Production Tissu avec picots revetus d'un materiau hydrosoluble
US20110144667A1 (en) 2009-09-08 2011-06-16 Anthony Richard Horton Hernia patch
ES2578080T3 (es) 2009-09-30 2016-07-20 Coloplast A/S Tela implantable en el cuerpo para reparar el suelo pélvico
US8734471B2 (en) 2009-10-01 2014-05-27 Coloplast A/S Method of implanting a fabric to repair a pelvic floor
US8470355B2 (en) 2009-10-01 2013-06-25 Covidien Lp Mesh implant
US8579922B2 (en) 2009-10-05 2013-11-12 Covidien Lp Method of suture identification and mesh marking for orienting and locating a mesh during hernia repair
FR2951069B1 (fr) 2009-10-09 2011-11-18 Sofradim Production Element de renfort d'un treillis
CN102844053B (zh) * 2009-11-25 2015-08-05 洛马林达大学医学中心 基于壳聚糖的止血织物
KR20090130277A (ko) 2009-11-29 2009-12-22 이정삼 단일공을 통한 복강경하 탈장수술에 이용되는 특수 인공막
FR2953709B1 (fr) 2009-12-16 2012-08-10 Sofradim Production Treillis renforce par une bague
US9510925B2 (en) 2010-02-02 2016-12-06 Covidien Lp Surgical meshes
US8758800B2 (en) 2010-03-24 2014-06-24 Covidien Lp Therapeutic implant
US20110238094A1 (en) 2010-03-25 2011-09-29 Thomas Jonathan D Hernia Patch
CA2794338A1 (en) 2010-03-26 2011-09-29 Sofradim Production Implant for tissue repair
US8435307B2 (en) 2010-05-20 2013-05-07 Ces Advancements, Llc Reinforcement device with dissolvable layer and its use
US20110311632A1 (en) * 2010-06-16 2011-12-22 Abbott Vascular, Inc. Stable chitosan hemostatic external patch and methods of manufacture
US9211175B2 (en) 2010-07-08 2015-12-15 Covidien Lp Self-detachable medical devices
SG10201607262PA (en) * 2010-08-30 2016-10-28 Harvard College A High Strength Chitin Composite Material and Method of Making
CN201879864U (zh) 2010-09-17 2011-06-29 常州市康蒂娜医疗科技有限公司 一种外科修复补片
US9572907B2 (en) 2010-10-01 2017-02-21 Covidien Lp Implantable polymeric films
US8911504B2 (en) 2010-10-28 2014-12-16 Novus Scientific Ab Elastically deformable and resorbable medical mesh implant
US8753360B2 (en) 2010-11-08 2014-06-17 Covidien Lp Expandable mesh system and method of use therefor
US20120179176A1 (en) 2010-12-28 2012-07-12 Promethean Surgical Devices, Llc Apparatus and method for limiting surgical adhesions
FR2985270B1 (fr) 2011-12-29 2014-10-31 Sofradim Production Tricot avec bandes sans picots

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10517988B1 (en) 2018-11-19 2019-12-31 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation

Also Published As

Publication number Publication date
FR2995788A1 (fr) 2014-03-28
FR2995788B1 (fr) 2014-09-26
US20150202342A1 (en) 2015-07-23
CA2879765C (en) 2021-03-09
WO2014048982A1 (en) 2014-04-03
AU2013322689A1 (en) 2015-02-05
EP2900280B1 (de) 2018-08-01
US9750837B2 (en) 2017-09-05
CA2879765A1 (en) 2014-04-03
AU2013322689B2 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
US20120177719A1 (en) Medical device intended to come into contact with a patient's tissue and related manufacturing method
WO2013089493A1 (ko) 유착방지용 조성물, 이를 포함하는 유착방지기능을 갖는 수술용 메쉬 복합체 및 이의 제조 방법
EP2900280B1 (de) Blutstillendes pflaster und verfahren zur herstellung
EP2329074B1 (de) Verfahren zur behandlung cellulosischer formkörper
US20150299911A1 (en) Endless Fibres on the Basis of Hyaluronan Selectively Oxidized in the Position 6 of the N-Acetyl-D-Glucosamine Group, Preparation and Use Thereof, Threads, Staples, Yarns, Fabrics Made Thereof and Method for Modifying the Same
US20150158209A1 (en) Method for preparing a chitosan-based porous layer
Kim et al. Formation, antimicrobial activity, and controlled release from cotton fibers with deposited functional polymers
US10184032B2 (en) Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
JP5901112B2 (ja) セルロース多孔体ゲル
Kopańska et al. Combination of polylactide with cellulose for biomedical applications: a recent overview
US10624989B2 (en) Implant comprising oxidized cellulose and method for preparing such an implant
KR101111223B1 (ko) 나노 섬유로 구성된 생분해성 산화 셀룰로오스 부직포 및 이의 제조방법
ES2391067T3 (es) Asociación de una película y de un hidrogel a base de quitosano y sus aplicaciones en cirugía
KR101754857B1 (ko) 흡수성이 우수한 천연 기능성 섬유가 포함된 부직포의 제조방법
CN211096500U (zh) 一种即时穿刺透析型纳米纤维人工血管
KR100993006B1 (ko) 키토산으로 코팅된 알긴산 스폰지 및 이의 제조방법
WO2016046354A1 (en) Method for preparing chitosan matrices having improved mechanical properties
KR100987818B1 (ko) 수용성 키토산으로 코팅된 알긴산 스폰지 및 이의 제조방법
WO2021140331A1 (en) Antimicrobial fibres
JPH072904A (ja) キトサン又はその誘導体からなる成形体の製造方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150422

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20161104

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180307

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTC Intention to grant announced (deleted)
GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

INTG Intention to grant announced

Effective date: 20180604

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1023551

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180815

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013041233

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180801

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1023551

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181101

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181102

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181201

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181101

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013041233

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180930

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180925

26N No opposition filed

Effective date: 20190503

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20181101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20130925

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180801

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180801

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230822

Year of fee payment: 11

Ref country code: DE

Payment date: 20230822

Year of fee payment: 11